SN-38 Sensitizes BRCA-Proficient Ovarian Cancers to PARP Inhibitors through Inhibiting Homologous Recombination Repair

Shengbin Lin(Sun Yat-sen University), Guo Chen(Jinan University)
Disease Markers
October 11, 2022
Cited by 9


Related Papers